Identification of Potential Therapeutic Targets for Burkholderia cenocepacia by Comparative Transcriptomics

Background Burkholderia cenocepacia is an endemic soil dweller and emerging opportunistic pathogen in patients with cystic fibrosis (CF). The identification of virulence factors and potential therapeutic targets has been hampered by the genomic diversity within the species as many factors are not shared among the pathogenic members of the species. Methodology/Principal Findings In this study, global identification of putative virulence factors was performed by analyzing the transcriptome of two related strains of B. cenocepacia (one clinical, one environmental) under conditions mimicking cystic fibrosis sputum versus soil. Soil is a natural reservoir for this species; hence, genes induced under CF conditions relative to soil may represent adaptations that have occurred in clinical strains. Under CF conditions, several genes encoding proteins thought to be involved in virulence were induced and many new ones were identified. Our analysis, in combination with previous studies, reveals 458 strain-specific genes, 126 clinical-isolate-specific, and at least four species-specific genes that are induced under CF conditions. The chromosomal distribution of the induced genes was disproportionate to the size of the chromosome as genes expressed under soil conditions by both strains were more frequent on the second chromosome and those differentially regulated between strains were more frequent on the third chromosome. Conservation of these induced genes was established using the 11 available Bcc genome sequences to indicate whether potential therapeutic targets would be species-wide. Conclusions/Significance Comparative transcriptomics is a useful way to identify new potential virulence factors and therapeutic targets for pathogenic bacteria. We identified eight genes induced under CF conditions that were also conserved in the Bcc and may constitute particularly attractive therapeutic targets due to their signal sequence, predicted cellular location, and homology to known therapeutic targets.

[1]  R. Goldstein,et al.  Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers , 1995, Journal of bacteriology.

[2]  R. Welch,et al.  Role of Sigma E-Regulated Genes in Escherichia coli Uropathogenesis , 2006, Infection and Immunity.

[3]  Trinad Chakraborty,et al.  GenomeViz: visualizing microbial genomes , 2004, BMC Bioinformatics.

[4]  P. Vandamme,et al.  Burkholderia latens sp. nov., Burkholderia diffusa sp. nov., Burkholderia arboris sp. nov., Burkholderia seminalis sp. nov. and Burkholderia metallica sp. nov., novel species within the Burkholderia cepacia complex. , 2008, International journal of systematic and evolutionary microbiology.

[5]  B. Conway,et al.  Production of exopolysaccharide by Burkholderia cenocepacia results in altered cell-surface interactions and altered bacterial clearance in mice. , 2004, The Journal of infectious diseases.

[6]  T. Beveridge,et al.  Colonial Morphology of Burkholderia cepacia Complex Genomovar III: Implications in Exopolysaccharide Production, Pilus Expression, and Persistence in the Mouse , 2003, Infection and Immunity.

[7]  M. Whiteley,et al.  Nutritional Cues Control Pseudomonas aeruginosa Multicellular Behavior in Cystic Fibrosis Sputum , 2007, Journal of bacteriology.

[8]  J. Parke.  Burkholderia Cepacia: Friend or Foe? , 2000 .

[9]  Søren Brunak,et al.  Prediction of twin-arginine signal peptides , 2005, BMC Bioinformatics.

[10]  J. Govan,et al.  Pathogenicity of microbes associated with cystic fibrosis. , 1999, Microbes and infection.

[11]  Konstantinos T. Konstantinidis,et al.  Towards a Genome-Based Taxonomy for Prokaryotes , 2005, Journal of bacteriology.

[12]  P. Roholl,et al.  The Omp85 protein of Neisseria meningitidis is required for lipid export to the outer membrane , 2003, The EMBO journal.

[13]  L. M. Moreira,et al.  Differential Mucoid Exopolysaccharide Production by Members of the Burkholderia cepacia Complex , 2008, Journal of Clinical Microbiology.

[14]  M. Klein,et al.  Outer membrane protein D15 is conserved among Haemophilus influenzae species and may represent a universal protective antigen against invasive disease , 1997, Infection and immunity.

[15]  E M Rubin,et al.  Mapping the Burkholderia cenocepacia niche response via high-throughput sequencing , 2009, Proceedings of the National Academy of Sciences.

[16]  M. Valvano,et al.  Identification of Burkholderia cenocepacia Genes Required for Bacterial Survival In Vivo , 2004, Infection and Immunity.

[17]  M. D. Shulman.  Handbook of Soils and Climate in Agriculture , 1982 .

[18]  C. Herfst,et al.  Role of Flagella in Host Cell Invasion by Burkholderia cepacia , 2002, Infection and Immunity.

[19]  S. Brunak,et al.  Improved prediction of signal peptides: SignalP 3.0. , 2004, Journal of molecular biology.

[20]  Daniel Kahne,et al.  Identification of a Multicomponent Complex Required for Outer Membrane Biogenesis in Escherichia coli , 2005, Cell.

[21]  Adam Baldwin,et al.  The Burkholderia cepacia Epidemic Strain Marker Is Part of a Novel Genomic Island Encoding Both Virulence and Metabolism-Associated Genes in Burkholderia cenocepacia , 2004, Infection and Immunity.

[22]  Leo Eberl,et al.  Communication systems in the genus Burkholderia: global regulators and targets for novel antipathogenic drugs. , 2007, Future microbiology.

[23]  Haruo Watanabe,et al.  Opr86 Is Essential for Viability and Is a Potential Candidate for a Protective Antigen against Biofilm Formation by Pseudomonas aeruginosa , 2008, Journal of bacteriology.

[24]  D. Woods,et al.  Role of Ornibactin Biosynthesis in the Virulence ofBurkholderia cepacia: Characterization of pvdA, the Gene Encoding l-OrnithineN5-Oxygenase , 1999, Infection and Immunity.

[25]  Tom Coenye,et al.  Diversity and significance of Burkholderia species occupying diverse ecological niches. , 2003, Environmental microbiology.

[26]  C. Herfst,et al.  Attenuated Virulence of a Burkholderia cepacia Type III Secretion Mutant in a Murine Model of Infection , 2003, Infection and Immunity.

[27]  Luke E. Ulrich,et al.  Burkholderia xenovorans LB400 harbors a multi-replicon, 9.73-Mbp genome shaped for versatility , 2006, Proceedings of the National Academy of Sciences.

[28]  D. Simpson,et al.  Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis , 1997, Journal of clinical microbiology.

[29]  C. Mohr,et al.  Transcriptional and Posttranscriptional Control of Cable Pilus Gene Expression in Burkholderia cenocepacia , 2004, Journal of bacteriology.

[30]  Eduardo P C Rocha,et al.  The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients , 2008, Journal of bacteriology.

[31]  Expression in Escherichia coli of a high-molecular-weight protective surface antigen found in nontypeable and type b Haemophilus influenzae , 1990, Infection and immunity.

[32]  J. Lipuma.  Burkholderia cepacia complex: a contraindication to lung transplantation in cystic fibrosis? , 2001, Transplant infectious disease : an official journal of the Transplantation Society.

[33]  L. Eberl,et al.  Killing of Caenorhabditis elegans by Burkholderia cepacia is controlled by the cep quorum‐sensing system , 2003, Cellular microbiology.

[34]  Martin Ester,et al.  Sequence analysis PSORTb v . 2 . 0 : Expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis , 2004 .

[35]  A. Forsgren,et al.  Developing a nontypeable Haemophilus influenzae (NTHi) vaccine. , 2000, Vaccine.

[36]  A. Meinke,et al.  Bacterial genomes pave the way to novel vaccines. , 2004, Current opinion in microbiology.

[37]  T. Coenye,et al.  An epidemic Burkholderia cepacia complex strain identified in soil , 2002, The Lancet.

[38]  C. Herfst,et al.  Cellular aspects of Burkholderia cepacia infection. , 2001, Microbes and infection.

[39]  N. C. Gey van Pittius,et al.  Mycosin-1, a subtilisin-like serine protease of Mycobacterium tuberculosis, is cell wall-associated and expressed during infection of macrophages , 2002, BMC Microbiology.

[40]  H. Mobley,et al.  Outer Membrane Antigens of the Uropathogen Proteus mirabilis Recognized by the Humoral Response during Experimental Murine Urinary Tract Infection , 2008, Infection and Immunity.

[41]  Adherence and autoaggregation phenotypes of a Burkholderia cenocepacia cable pilus mutant. , 2003, FEMS microbiology letters.

[42]  R. M. Wooten,et al.  The Moraxella catarrhalis Autotransporter McaP Is a Conserved Surface Protein That Mediates Adherence to Human Epithelial Cells through Its N-Terminal Passenger Domain , 2006, Infection and Immunity.

[43]  S. Cardona,et al.  A Functional Phenylacetic Acid Catabolic Pathway Is Required for Full Pathogenicity of Burkholderia cenocepacia in the Caenorhabditis elegans Host Model , 2008, Journal of bacteriology.

[44]  C. Mohr,et al.  Genetic Characterization of a Multicomponent Signal Transduction System Controlling the Expression of Cable Pili in Burkholderia cenocepacia , 2004, Journal of bacteriology.

[45]  J. Lipuma,et al.  Lack of cable pili expression by cblA-containing Burkholderia cepacia complex. , 2002, Microbiology.

[46]  Ryan T Gill,et al.  Gene expression changes linked to antimicrobial resistance, oxidative stress, iron depletion and retained motility are observed when Burkholderia cenocepacia grows in cystic fibrosis sputum , 2008, BMC infectious diseases.

[47]  H. Schweizer.  Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions. , 2003, Genetics and molecular research : GMR.

[48]  J. Govan,et al.  Burkholderia cepacia Produces a Hemolysin That Is Capable of Inducing Apoptosis and Degranulation of Mammalian Phagocytes , 1998, Infection and Immunity.

[49]  Cameron Ackerley,et al.  Interaction of cblA/adhesin‐positive Burkholderia cepacia with squamous epithelium , 2002, Cellular microbiology.

[50]  J. Mekalanos,et al.  Determination of the transcriptome of Vibrio cholerae during intraintestinal growth and midexponential phase in vitro , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Jin-Town Wang,et al.  Identification and Characterization of an Organic Solvent Tolerance Gene in Helicobacter pylori , 2007, Helicobacter.

[52]  S. Majumdar,et al.  Importance of the Ornibactin and Pyochelin Siderophore Transport Systems in Burkholderia cenocepacia Lung Infections , 2004, Infection and Immunity.

[53]  S. Brunak,et al.  SHORT COMMUNICATION Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites , 1997 .

[54]  K. Konstantinidis,et al.  Genomic insights that advance the species definition for prokaryotes. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[55]  Ryan T Gill,et al.  A comparison of alternative 60-mer probe designs in an in-situ synthesized oligonucleotide microarray , 2006, BMC Genomics.

[56]  M. Sousa,et al.  Crystal structure of Skp, a prefoldin-like chaperone that protects soluble and membrane proteins from aggregation. , 2004, Molecular cell.

[57]  Steven C. Slater,et al.  Genome Sequences of Three Agrobacterium Biovars Help Elucidate the Evolution of Multichromosome Genomes in Bacteria , 2009, Journal of bacteriology.

[58]  P. Sokol,et al.  Distribution and Expression of the ZmpA Metalloprotease in the Burkholderia cepacia Complex , 2005, Journal of bacteriology.